HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology. Concurrent with the investment, HEALWELL… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high… Read More
VANCOUVER, BC, TORONTO ON, & MONTREAL, QC – adMare BioInnovations is proud to celebrate the ongoing success of its National adMare Tx Accelerator program in advancing early-stage Canadian therapeutic (Tx)… Read More
Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other mesothelin (MSLN) expressing cancers VANCOUVER,… Read More
People with opioid use disorder who received methadone were less likely to discontinue treatment compared with those who received buprenorphine/naloxone, according to a new study involving UBC faculty of medicine… Read More
